Ernexa Therapeutics Inc. (ERNA) IPO - S-1 Filing, Stock & Insider Activity
Ernexa Therapeutics Inc. IPO - Status & S-1 Filing
- Ticker: ERNA
- Status: Registered - S-1 filed with the SEC
- S-1 filed: 2026-02-03
- Expected price range: not yet disclosed (set in a later S-1/A or pricing amendment)
- SEC CIK: 0000748592 · View the S-1 on SEC EDGAR →
Ernexa Therapeutics Inc. is pre-IPO, so no insider Form 4 transactions have been filed yet. Once insiders begin reporting trades after the offering, they will appear on this page automatically.
Track every registration update on the InsiderAlpha IPO tracker.
Last SEC filing
Ernexa Therapeutics Inc. (ERNA) - no SEC Form 4 insider filings recorded in the last 90 days. 3 Form 8-K material event filings were reported by ERNA in the last 90 days. InsiderAlpha tracks every ERNA SEC filing - Form 4, Form 144, and 8-K - in real time, including Rule 10b5-1 plan detection.
About Ernexa Therapeutics Inc. (ERNA)
Ernexa Therapeutics Inc. trades under the ticker ERNA. InsiderAlpha tracks 3 primary SEC Form 4 filings from 2 reporting insiders for ERNA since 2024, sourced directly from SEC EDGAR.
| Sector | Health Care insider trading |
|---|---|
| SIC classification | Pharmaceutical Preparations (SIC 2834) |
| SEC CIK | 0000748592 |
90-Day SEC Filing Activity
| Form 8-K filings (90d) | 3 |
|---|---|
| Latest Form 4 filing | 2026-02-18 |
Recent ERNA Insider Transactions (Form 4)
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Charles Cherington | 10% Owner | P - Open-market purchase | 4.00M | $0.50 | $2.00M | SEC | |
| Sandra M. Gurrola | Sr. VP of Finance | M - Option exercise | 30 | - | - | SEC | |
| Charles Cherington | 10% Owner | P - Open-market purchase | 4.77M | - | - | SEC | |
| Charles Cherington | 10% Owner | P - Open-market purchase | 1.24M | - | - | SEC | |
| Charles Cherington | 10% Owner | P - Open-market purchase | 5.42M | - | - | SEC | |
| Charles Cherington | 10% Owner | P - Open-market purchase | 1.56M | - | - | SEC | |
| Charles Cherington | 10% Owner | J - Other acquisition / disposition | 2.82M | $0.50 | $1.41M | SEC | |
| Charles Cherington | 10% Owner | P - Open-market purchase | 261.8K | - | - | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Ernexa Therapeutics Inc. (ERNA). Updated in real time as new filings are submitted to the SEC.
Recent ERNA Form 8-K Material Events
- - Item 7.01, 9.01 [SEC]
- - Item 5.07, 9.01 [SEC]
- - Item 5.02, 9.01 [SEC]
- - Item 5.03, 9.01 [SEC]
- - Other · neutral [SEC]
Trading halt (T3) for ERNA. ERNA
Recent Insider Filings
- - Charles Cherington (10% Owner)
- - Sandra M. Gurrola (Sr. VP of Finance)
- - Charles Cherington (10% Owner)
Form 4 Transaction Code Reference
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in ERNA insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
ERNA Insider Trading - FAQ
- What is the latest insider trade for ERNA?
- Ernexa Therapeutics Inc. (ERNA) had 0 insider filings in the last 90 days, with the most recent on 2026-02-18. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
- How many insiders are buying ERNA stock?
- 0 insider purchases of ERNA were filed in the last 90 days.
- How many insiders are selling ERNA stock?
- 0 insider sales of ERNA were filed in the last 90 days.
- Where can I see ERNA SEC filings (Form 4, 10-K, 10-Q, 8-K)?
- This page tracks ERNA Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care Companies with Insider Activity
Other companies in the InsiderAlpha index with a significant SEC Form 4 insider-trading footprint:
- $ETNB 89bio, Inc.
- $EWTX Edgewise Therapeutics, Inc.
- $FBIO Fortress Biotech, Inc.
- $GNPX Genprex, Inc.
- $GOVX GeoVax Labs, Inc.
- $GRI GRI Bio, Inc.
- $GRML Greenland Mines Ltd
- $GTBP GT Biopharma, Inc.
- $HYEX HEALTHY EXTRACTS INC.
- $ICU SeaStar Medical Holding Corp
Related Companies - Recent Insider Activity
- UNITED THERAPEUTICS Corp (UTHR)
- Liquidia Corp (LQDA)
- BeOne Medicines Ltd. (ONC)
- PERRIGO Co plc (PRGO)
- Processa Pharmaceuticals, Inc. (PCSA)
- Nuvalent, Inc. (NUVL)
- CYTOKINETICS INC (CYTK)
- Elanco Animal Health Inc (ELAN)
- Avalo Therapeutics, Inc. (AVTX)
- NATURES SUNSHINE PRODUCTS INC (NATR)
Learn More
- What is SEC Form 4?
- How to read insider buying signals
- Rule 10b5-1 trading plans explained
- The cluster buying signal
Open the live ERNA dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.